Two days after being taken to hospital Malcolm, a dad-of-four and who was "worshipped" by his three step-children, was ...

Lauren Williams, 74, is trying to raise awareness about the dangers of experimental trials after her husband Malcolm, a ...

A man who 'jumped at the opportunity' to take part in a miracle drug trial died with days of starting the treatment, says his ...

A leading scientist, a businesswoman and a disease-free patient come together to tell the full story of the promising ...

CytomX Therapeutics' innovative cancer therapies show promise with the CX-2051 and CX-801 trials. Explore the potential of ...

A new treatment for advanced endometrial cancer has been approved for use on the NHS, after women with the disease were found ...

Basel, August 7, 2025 – Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in generic and biosimilar medicines, today presents its financial results for the first half of 2025. Growth in this document ...

Even though oncology segment revenue inched up just 1 percent year over year, the firm lifted full-year expectations slightly ...

In results from a Phase Ib study, Hernexeos showed a 75 percent response rate and more than half of patients responded for at least six months.